Long-term Side Effects of Radiation for the Treatment of Hodgkin's Lymphoma

John Han-Chih Chang, MD and Kenneth Blank, MD
Ultima Vez Modificado: 1 de noviembre del 2001

Share article

Dear OncoLink "Ask the Experts,"
I am looking for data or research that explains long term side effects for survivors of radiation therapy for the treatment of Hodgkin's Lymphoma IIA. I received this treatment in 1986 and have since developed a hypothyroidism and diabetes mellitis. What is the link between radiation and long term side effects?

John Han-Chih Chang, MD and Kenneth Blank, MD, OncoLink Editorial Assistants, respond:

Dear DC,
Thank you for your interest and question.

The side effects of radiation depend on where the radiation is directed. For example, patients with stomach cancer haveradiation directed at the abdomen that may cause nausea and vomiting. In contrast, a patient with lung cancer has radiationdirected at the lung and may get a cough.

Hodgkin's Disease can occur anywhere in the body, and therefore it is unclear where the radiation you received was directed. However, it is not uncommon for a patient with Hodgkin's Disease to receive radiation to the lymph node areas in the neck. The thyroid gland is located near these lymph nodes and often receives a considerable amount of radiation. Hypothyroidism is a known side effect when the thyroid gland receives radiation and may explain your case.

The association of diabetes and radiation is unclear. Diabetes occurs when the body fails to produce insulin, which is made by the pancreas. The pancreas is located in the abdomen. There are case reports of patients developing diabetes following abdominal radiation. However, a very large study which followed children with abdominal cancer who had abdominal radiation found that their risk of developing diabetes was no greater than for the population as a whole.

Studies outline new options for the standard treatment of various lymphoma types

Dec 7, 2010 - Rituximab may be a better option than watchful waiting in some lymphoma patients, and a new treatment option appears effective for relapsed or refractory Hodgkin's lymphoma, according to two studies being presented at the annual meeting of the American Society of Hematology, held from Dec. 4 to 7 in Orlando, Fla. Other research being presented will highlight new options for the standard treatment of advanced asymptomatic follicular lymphoma; mantle cell lymphoma; and early, unfavorable Hodgkin's disease.

I Wish You Knew

Understanding prostate cancer screening

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información